‘EQUAL’ study: Researchers aim to identify signs of certain lung cancers earlier with blood test
When many people think about lung cancer, they often associate it with smoking, but researchers at Dana-Farber Cancer Institute say some of the people diagnosed have never even used tobacco.
The EQUAL study is looking at whether a simple blood test could help identify signs of certain lung cancers earlier, particularly in communities that have historically been underrepresented in cancer research.
Researchers analyze participants’ blood for the two most common EGFR mutations associated with some lung cancers.
https://www.boston25news.com/news/local/equal-study-researchers-aim-identify-signs-certain-lung-cancers-earlier-with-blood-test/43LXTFPYS5GYBEXUMXZGVIVNDA/
#news #research #lungcancer #doctors
Follow Boston 25 News on:
YouTube: https://www.youtube.com/@Boston25News
Facebook -- https://www.facebook.com/Boston25News
X -- https://x.com/boston25
Instagram -- https://www.instagram.com/boston25/
TikTok -- https://www.tiktok.com/@b25news?lang=en
Download the Boston 25 News app: https://www.boston25news.com/mobile-apps/
Video Summary
AI GeneratedResearchers at Dana-Farber are conducting the EQUAL study to determine if a simple blood test can detect early signs of lung cancer, specifically targeting non-smokers. The study focuses on underrepresented Hispanic, Latino, and Asian populations to address healthcare disparities and provide early intervention through mutation detection and CT scans.